Associated tags: Pharmacy, Health, AmerisourceBergen, Pharmaceutical, General Health, Patient, Pharmaceutical industry, Professional Services
Locations: FLORIDA, CALIFORNIA, OHIO, TEXAS, BELGIUM, MASSACHUSETTS, UNITED STATES, NORTH AMERICA, PENNSYLVANIA, MAINE, NEVADA, USA, CANADA, BRAZIL, NEW YORK
Women,
Technology,
Data management,
Practice Management,
Health,
Pharmaceutical,
Mobile,
Wireless,
Consumer,
General Health,
MEN,
Health informatics Chronically Simple will add to Innomars robust digital offerings that enhance the patient journey and simplify their experience.
Key Points:
- Chronically Simple will add to Innomars robust digital offerings that enhance the patient journey and simplify their experience.
- Innomars acquisition of Chronically Simple is part of the companys continued focus on offering simple and streamlined solutions that empower patients and care teams and build connections in healthcare.
- At Innomar, we believe in patient-centric healthcare, and Chronically Simple puts the power in the hands of the patient, said Guy Payette, President of Innomar.
- Patients can subscribe to Chronically Simple services online (chronicallysimple.com) or by downloading the application through the App Store or Google Play.
Health,
Pharmaceutical,
Manufacturing,
Other Manufacturing,
Professional services,
Other Professional Services,
Medical Supplies,
Pharmacy,
Dividend,
Shareholders,
Pharmaceutical industry The Board of Directors ofAmerisourceBergen Corporation (NYSE:ABC) today declared a quarterly cash dividend of$0.40per common share, payableJune 3, 2019, to stockholders of record at the close of business onMay 20, 2019.
Key Points:
- The Board of Directors ofAmerisourceBergen Corporation (NYSE:ABC) today declared a quarterly cash dividend of$0.40per common share, payableJune 3, 2019, to stockholders of record at the close of business onMay 20, 2019.
- AmerisourceBergenprovides pharmaceutical products, value-driving services and business solutions that improve access to care.
- Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain.
- Global manufacturers depend on us for services that drive commercial success for their products.
DENVER, May 3, 2019 /PRNewswire/ -- Today, Leiters and Besse Medical announced that they have entered into a national agreement to provide ophthalmic medications that are compatible with Besse Medical's inventory management systems, CubixxMD and PODIS Plus.
Key Points:
- DENVER, May 3, 2019 /PRNewswire/ -- Today, Leiters and Besse Medical announced that they have entered into a national agreement to provide ophthalmic medications that are compatible with Besse Medical's inventory management systems, CubixxMD and PODIS Plus.
- This new agreement enables Leiters' full suite of ophthalmic medications to arrive individually serialized, lot-tracked and integrated into Besse Medical's inventory management solutions with no additional printing, labeling or processing required.
- "We are excited to work with Besse Medical to combine our high-quality ophthalmic medicines with their market leading inventory management systems to provide a win-win for customers".
- "At Besse Medical, we're always trying to find ways to create efficiencies and automations for our customers through inventory management," said Eric Besse, Vice President of Specialty Sales and Solutions at Besse Medical.
Health,
Pharmaceutical,
Medical Supplies,
General Health,
AmerisourceBergen,
Veterinary physician,
Veterinary medicine,
Conference call,
New York Stock Exchange,
Companies,
Economy of the United States,
Economy of New York City AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter Fiscal 2019 on Thursday, May 2, 2019, prior to the opening of trading on the New York Stock Exchange.
Key Points:
- AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter Fiscal 2019 on Thursday, May 2, 2019, prior to the opening of trading on the New York Stock Exchange.
- Participating in the conference call will be:
The dial-in number for the live call will be (612) 326-1019.
- Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
- Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain.
Retrieved on:
Tuesday, February 5, 2019
The Board of Directors ofAmerisourceBergen Corporation (NYSE:ABC) today declared a quarterly cash dividend of$0.40per common share, payableMarch 4, 2019, to stockholders of record at the close of business onFebruary 19, 2019.
Key Points:
- The Board of Directors ofAmerisourceBergen Corporation (NYSE:ABC) today declared a quarterly cash dividend of$0.40per common share, payableMarch 4, 2019, to stockholders of record at the close of business onFebruary 19, 2019.
- AmerisourceBergenprovides pharmaceutical products, value-driving services and business solutions that improve access to care.
- Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain.
- Global manufacturers depend on us for services that drive commercial success for their products.
Retrieved on:
Thursday, January 31, 2019
Retrieved on:
Tuesday, September 11, 2018
Biology,
Health,
Supply chain management,
Nature,
Drug discovery,
Health policy,
Medicinal chemistry,
Therapy,
Logistics,
Gene therapy,
Supply chain Together, Vineti and World Courier will offer a holistic, integrated logistics and supply chain solution that will enable cell and gene therapy developers to scale their treatments, care networks, and manufacturing quickly and safely.
Key Points:
- Together, Vineti and World Courier will offer a holistic, integrated logistics and supply chain solution that will enable cell and gene therapy developers to scale their treatments, care networks, and manufacturing quickly and safely.
- Vineti's software solution supports all the major stakeholders in the cell and gene therapy ecosystem, helping everyone from healthcare providers to biopharma and manufacturers exert efficiency and control.
- "Together, Vineti and World Courier provide a powerful option that helps move innovative therapies into mainstream healthcare.
- About World Courier World Courier is a global specialty logistics company that designs world-class supply chain programs in complete alignment with customers' business goals.
Retrieved on:
Tuesday, September 11, 2018
Biology,
Health,
Supply chain management,
Nature,
Drug discovery,
Health policy,
Medicinal chemistry,
Therapy,
Logistics,
Gene therapy,
Supply chain Together, Vineti and World Courier will offer a holistic, integrated logistics and supply chain solution that will enable cell and gene therapy developers to scale their treatments, care networks, and manufacturing quickly and safely.
Key Points:
- Together, Vineti and World Courier will offer a holistic, integrated logistics and supply chain solution that will enable cell and gene therapy developers to scale their treatments, care networks, and manufacturing quickly and safely.
- Vineti's software solution supports all the major stakeholders in the cell and gene therapy ecosystem, helping everyone from healthcare providers to biopharma and manufacturers exert efficiency and control.
- "Together, Vineti and World Courier provide a powerful option that helps move innovative therapies into mainstream healthcare.
- About World Courier World Courier is a global specialty logistics company that designs world-class supply chain programs in complete alignment with customers' business goals.
Retrieved on:
Wednesday, August 8, 2018
LOS ALTOS, Calif., Aug. 8, 2018 /PRNewswire/ -- Netskope , the leader in cloud security, today named pharmaceutical company and Fortune 20 member AmerisourceBergen as the winner of the inaugural Cloud Security Excellence Award, recognizing the organization's commitment to secure cloud enablement.
Key Points:
- LOS ALTOS, Calif., Aug. 8, 2018 /PRNewswire/ -- Netskope , the leader in cloud security, today named pharmaceutical company and Fortune 20 member AmerisourceBergen as the winner of the inaugural Cloud Security Excellence Award, recognizing the organization's commitment to secure cloud enablement.
- Through its use of the Netskope Security Cloud, AmerisourceBergen enables its employees to take full advantage of the cloud and web, without jeopardizing security.
- "AmerisourceBergen's approach mirrors the Netskope philosophy so closely, and it is an honor to award them with our inaugural Cloud Security Excellence Award."
- To view a demo of the Netskope Security Cloud, visit booth #L13 at Black Hat or https://www.netskope.com/platform/
Netskope is the leader in cloud security.
